BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21050726)

  • 21. Imaging of serotonin and dopamine transporters in the living human brain.
    Kuikka JT; Tiihonen J; Bergström KA; Karhu J; Hartikainen P; Viinamäki H; Länsimies E; Lehtonen J; Hakola P
    Eur J Nucl Med; 1995 Apr; 22(4):346-50. PubMed ID: 7607266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects.
    Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y
    Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin transporter and dopamine transporter imaging in the canine brain.
    Peremans K; Goethals I; De Vos F; Dobbeleir A; Ham H; Van Bree H; Van Heeringen C; Audenaert K
    Nucl Med Biol; 2006 Oct; 33(7):907-13. PubMed ID: 17045171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
    Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
    Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans.
    Bergström KA; Kuikka JT; Ahonen A; Vanninen E
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):128-31. PubMed ID: 7632756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines.
    Okada T; Fujita M; Shimada S; Sato K; Schloss P; Watanabe Y; Itoh Y; Tohyama M; Nishimura T
    Nucl Med Biol; 1998 Jan; 25(1):53-8. PubMed ID: 9466362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy.
    Ryding E; Ahnlide JA; Lindström M; Rosén I; Träskman-Bendz L
    Psychiatry Res; 2006 Dec; 148(2-3):195-203. PubMed ID: 17085020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype.
    van Dyck CH; Malison RT; Staley JK; Jacobsen LK; Seibyl JP; Laruelle M; Baldwin RM; Innis RB; Gelernter J
    Am J Psychiatry; 2004 Mar; 161(3):525-31. PubMed ID: 14992979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High resolution micro-SPECT scanning in rats using 125I beta-CIT: effects of chronic treatment with carbamazepine.
    Cain SM; Ruest T; Pimlott S; Patterson J; Duncan R; Dewar D; Sills GJ
    Epilepsia; 2009 Aug; 50(8):1962-70. PubMed ID: 19453722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin Transporter Binding in the Diencephalon Is Reduced in Insulin-Resistant Obese Humans.
    Versteeg RI; Koopman KE; Booij J; Ackermans MT; Unmehopa UA; Fliers E; la Fleur SE; Serlie MJ
    Neuroendocrinology; 2017; 105(2):141-149. PubMed ID: 27626923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour.
    Tiihonen J; Kuikka JT; Bergström KA; Karhu J; Viinamäki H; Lehtonen J; Hallikainen T; Yang J; Hakola P
    Eur J Nucl Med; 1997 Oct; 24(10):1253-60. PubMed ID: 9323266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity.
    Kim SE; Lee WY; Choe YS; Kim JH
    Neurol Res; 1999 Apr; 21(3):255-61. PubMed ID: 10319333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [123I]beta-CIT SPECT analysis.
    Scherfler C; Boesch SM; Donnemiller E; Seppi K; Weirich-Schwaiger H; Goebel G; Virgolini I; Wenning GK; Poewe W
    Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1084-90. PubMed ID: 16699769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loudness dependence of auditory evoked potentials (LDAEP) correlates with the availability of dopamine transporters and serotonin transporters in healthy volunteers-a two isotopes SPECT study.
    Lee IH; Yang YK; Chen PS; Huang HC; Yeh TL; Lu RB; Chiu NT; Yao WJ; Lin SH
    Psychopharmacology (Berl); 2011 Apr; 214(3):617-24. PubMed ID: 21072504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of rs591323 on serotonin transporter availability in healthy male subjects.
    Pak K; Nam HY; Shin S; Kim K; Lee MJ; Kim EJ; Lee JM; Kim SJ; Kim IJ
    Ann Nucl Med; 2018 Aug; 32(7):431-436. PubMed ID: 29774458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.
    Malison RT; Price LH; Berman R; van Dyck CH; Pelton GH; Carpenter L; Sanacora G; Owens MJ; Nemeroff CB; Rajeevan N; Baldwin RM; Seibyl JP; Innis RB; Charney DS
    Biol Psychiatry; 1998 Dec; 44(11):1090-8. PubMed ID: 9836013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report.
    Reneman L; Booij J; Lavalaye J; de Bruin K; Reitsma JB; Gunning B; den Heeten GJ; van Den Brink W
    Psychopharmacology (Berl); 2002 Jan; 159(3):335-40. PubMed ID: 11862367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of striatal dopamine transporter function in rats by in vivo beta-[123I]CIT pinhole SPECT.
    Scherfler C; Donnemiller E; Schocke M; Dierkes K; Decristoforo C; Oberladstätter M; Kolbitsch C; Zschiegner F; Riccabona G; Poewe W; Wenning G
    Neuroimage; 2002 Sep; 17(1):128-41. PubMed ID: 12482072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.